{
    "2020-08-06": [
        [
            {
                "time": "",
                "orginal_text": "白云山(600332.SH)：医药公司拟通过增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
                "features": {
                    "keywords": [
                        "白云山",
                        "医药公司",
                        "增资扩股",
                        "战略合作伙伴",
                        "管理层",
                        "核心骨干员工持股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "广州医药上市，最新进展公布",
                "features": {
                    "keywords": [
                        "广州医药",
                        "上市",
                        "最新进展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "白云山(00874.HK)：广州医药拟增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
                "features": {
                    "keywords": [
                        "白云山",
                        "广州医药",
                        "增资扩股",
                        "战略合作伙伴",
                        "管理层",
                        "核心骨干员工持股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "白云山：拟对广州医药增资扩股不高于9.6亿元",
                "features": {
                    "keywords": [
                        "白云山",
                        "广州医药",
                        "增资扩股",
                        "9.6亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}